🇺🇸 FDA

Company profile · Sponsor

S.L

CNTB · NYSE pharma SAN DIEGO, CA, EU
Pipeline
15
Drugs
0
Patents
8

Quick answer

S.L (CNTB) is a pharma company. headquartered in SAN DIEGO, CA, EU. listed on NYSE. NovaPharmaNews links 15 pipeline programs, 0 drugs, and 8 patents to this profile..

Company facts

Ticker CNTB
Exchange NYSE
Company type pharma
Headquarters SAN DIEGO, CA, EU
SEC CIK 0001835268

Pipeline (15)

Search pipeline →

  1. Acetaminophen

    S.L

    Patency of the Ductus Arteriosus

    phase 3 small molecule completed

    1 trial

  2. CBP-201

    S.L

    Atopic Dermatitis

    phase 3 small molecule active

    2 trials

  3. CBP-201

    S.L

    Chronic Rhinosinusitis With Nasal Polyps

    phase 2 small molecule terminated

    1 trial

  4. CBP-201

    S.L

    Moderate-to-severe Atopic Dermatitis

    phase 2 small molecule completed

    2 trials

  5. CBP-201

    S.L

    Moderate to Severe Persistent Asthma

    phase 2 small molecule completed

    1 trial

  6. Double-Blind 0.2mg CBP-307

    S.L

    Moderate to Severe Ulcerative Colitis

    phase 2 small molecule completed

    1 trial

  7. Rademikibart in prefilled syringe

    S.L

    Asthma Acute

    phase 2 other active

    1 trial

  8. Rademikibart in prefilled syringe

    S.L

    COPD Acute Exacerbation

    phase 2 other active

    1 trial

  9. umbilical cord blood (hUCB) cells

    S.L

    Cerebral Palsy

    phase 2 mab completed

    1 trial

  10. CBP-174

    S.L

    Healthy Adult Subjects

    phase 1 small molecule completed

    1 trial

  11. CBP-307

    S.L

    Healthy Adult Subjects

    phase 1 small molecule completed

    1 trial

  12. CBP-307

    S.L

    Autoimmune Diseases

    phase 1 small molecule completed

    2 trials

  13. Glycerol Phenylbutyrate 1100 MG/ML [Ravicti]

    S.L

    STXBP1 Encephalopathy With Epilepsy, SLC6A1 Neurodevelopmental Disorder

    phase 1 small molecule active

    1 trial

  14. Test drug (T1): CBP-201 injection (pre-filled syringe, 150 mg/1 mL)

    S.L

    Healthy Adult Subjects

    phase 1 mab completed

    1 trial

  15. vitamin D3

    S.L

    X-linked Adrenoleukodystrophy

    phase 1 other completed

    1 trial

Patents (8)

Search patents →

  1. US 12311017

    Identification of immunologically protective neo-epitopes for the treatment of cancers

    Expires Mon May 22 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 12251378

    Long-acting local anesthetic formulation

    Expires Mon Mar 13 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 12202822

    Addition salt of S1P1 receptor agonist and crystal form thereof, and pharmaceutical composition

    Expires Mon Jan 16 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 12156879

    Combining BACE1 inhibitors with mGluR agonists for Alzheimer's disease therapy

    Expires Mon Nov 28 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 12060555

    MicroRNA-33 inhibitors and use thereof in the treatment of pulmonary fibrosis

    Expires Mon Aug 08 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 12029787

    Method for generating recombinant poxviruses

    Expires Mon Jul 04 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 12018255

    Compositions and methods for treating disorders of genomic imprinting

    Expires Mon Jun 20 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 11952419

    Reagents and methods for treating cancer and autoimmune disease

    Expires Mon Apr 04 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

What is S.L?

S.L (CNTB) is a pharma company. headquartered in SAN DIEGO, CA, EU. listed on NYSE. NovaPharmaNews links 15 pipeline programs, 0 drugs, and 8 patents to this profile..

What pipeline programs does S.L sponsor?

We track 15 ClinicalTrials.gov-linked programs for S.L, including Acetaminophen and 14 more. Open each program for phase, modality, NCT IDs, and indication details.

Where does S.L company data come from?

Profiles combine SEC EDGAR (CIK/ticker), ClinicalTrials.gov sponsor links, FDA drug records, and USPTO patent metadata. See our data sources page. This profile is for professional reference, not investment advice.